<?xml version="1.0" encoding="UTF-8"?>
<p>Sustainable Development Goal (SDG) 3, “to ensure healthy lives and promote well-being for all at all ages” [
 <xref rid="pmed.1003042.ref001" ref-type="bibr">1</xref>], together with the Joint United Nations Programme on HIV/AIDS (UNAIDS) fast-track strategy, explicitly call to end the pandemic by 2030 [
 <xref rid="pmed.1003042.ref002" ref-type="bibr">2</xref>]. In 2017, about 37 million people were living with human immunodeficiency virus (HIV) worldwide, 70% of whom were residing in sub-Saharan Africa (SSA) [
 <xref rid="pmed.1003042.ref003" ref-type="bibr">3</xref>]. The countries in Eastern and Southern Africa are especially severely affected by the pandemic, with general population prevalences ranging from 5% in Tanzania to 27% in eSwatini (former Swaziland) [
 <xref rid="pmed.1003042.ref003" ref-type="bibr">3</xref>]. Mounting evidence suggests that these HIV epidemics are heterogeneous [
 <xref rid="pmed.1003042.ref004" ref-type="bibr">4</xref>,
 <xref rid="pmed.1003042.ref005" ref-type="bibr">5</xref>] and that the transmission of HIV is largely concentrated across clustered micro-epidemics of different scales [
 <xref rid="pmed.1003042.ref006" ref-type="bibr">6</xref>,
 <xref rid="pmed.1003042.ref007" ref-type="bibr">7</xref>]. As these high-prevalence areas are likely important drivers of the epidemic [
 <xref rid="pmed.1003042.ref008" ref-type="bibr">8</xref>,
 <xref rid="pmed.1003042.ref009" ref-type="bibr">9</xref>], identifying their location and underlying determinants is essential to further optimise HIV prevention and treatment interventions.
</p>
